EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The Glucose Management Indicator: Time to Change Course?

Elizabeth Selvin iD

Diabetes Care · 01.06.2024 · 47 (6) · 906-914

DOI: 10.2337/dci23-0086 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diabetes Care, online erschienen am 31.01.2024. Verfasst von Elizabeth Selvin. Beteiligte Einrichtung: Department of Epidemiology and the Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health,…. Hauptthemen laut MEDLINE: Glycated Hemoglobin, Blood Glucose, Blood Glucose Self-Monitoring. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Laboratory measurement of hemoglobin A1c (HbA1c) has, for decades, been the standard approach to monitoring glucose control in people with diabetes. Continuous glucose monitoring (CGM) is a revolutionary technology that can also aid in the monitoring of glucose control. However, there is uncertainty in how best to use CGM technology and its resulting data to improve control of glucose and prevent complications of diabetes. The glucose management indicator, or GMI, is an equation used to estimate HbA1c based on CGM mean glucose. GMI was originally proposed to simplify and aid in the interpretation of CGM data and is now provided on all standard summary reports (i.e., average glucose profiles) produced by different CGM manufacturers. This Perspective demonstrates that GMI performs poorly as an estimate of HbA1c and suggests that GMI is a concept that has outlived its usefulness, and it argues that it is preferable to use CGM mean glucose rather than converting glucose to GMI or an estimate of HbA1c. Leaving mean glucose in its raw form is simple and reinforces that glucose and HbA1c are distinct. To reduce patient and provider confusion and optimize glycemic management, mean CGM glucose, not GMI, should be used as a complement to laboratory HbA1c testing in patients using CGM systems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycated HemoglobinBlood GlucoseBlood Glucose Self-MonitoringHumansDiabetes MellitusGlycemic Control

Substanzen

Glycated HemoglobinBlood Glucose

Autor:innen und Institutionen

  • Department of Epidemiology and the Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
  • Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, MD.

ORCID-Profile: Elizabeth Selvin

Förderung

  • NHLBI NIH HHS
  • NIDDK NIH HHS
  • NIA NIH HHS
  • NIH/NIA
  • NIH/NIDDK
  • NIH/NHLBI

Zitieren

APA

Selvin, E. (2024). The Glucose Management Indicator: Time to Change Course?. Diabetes Care, 47(6), 906-914. https://doi.org/10.2337/dci23-0086

Vancouver

Selvin E. The Glucose Management Indicator: Time to Change Course?. Diabetes Care. 2024;47(6):906-914. doi:10.2337/dci23-0086

BibTeX
@article{Selvin2024,
  author = {Selvin, Elizabeth},
  title = {The Glucose Management Indicator: Time to Change Course?},
  journal = {Diabetes Care},
  year = {2024},
  volume = {47},
  number = {6},
  pages = {906--914},
  doi = {10.2337/dci23-0086}
}
Kostenlos starten →